Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brief IV Ganciclovir Induction Followed by Oral Valganciclovir for CMV in SOT Patients
NCT00730769Phase 4Completed
- Start
- Mar 2004
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valganciclovir in cytomegalovirus infection (CMV). Started Mar 2004; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00730769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730769.